To: Cube who wrote (17291 ) 5/20/1998 3:10:00 PM From: ivan solotaroff Read Replies (1) | Respond to of 79490
Cube, I have devised the following acid test for PGDCEBs: 1) Do 75% of the news heads at the bottom of the Yahoo screen have the following phrase: "So and So and So, PC, Announce Class Periods for Security Action Complaints"? 2) Do the posters on the SI and Yahoo message threads speak of the CEO exclusively by his first name. I.e.: "If Tom won't listen to what the shareholders have to say, maybe he should at least care about his own holdings"? 3) Have those posters resorted to profanity in which the male reproductive organ of the accused poster is attached without a hyphen to his head? 3) Do they contain blanket accusations of market- maker duplicity? 4) Do rumors of an imminent takeover/buyout appear in those lovely blue private message screens SI provides the moment you join the thread? 5) Are the thread's self-styled TA wizards a) guaranteeing the thread that the chart is currently showing a double-bottom ("Hey, it looks like a W"), or b) resorting to fractions for time-frames for Stochastics, RSI, OBV, and CCI studies? Seriously: This, from Online Investor, sums it up in a nutshell: "Vivus: Life After Viagra? May 18, 1998 - The company has recently been sued, watched its share price get decimated, and seen a new competitor introduce a pill that successfully treats impotence with few side effects. The lawsuit, which is now being treated as a class action, was prompted by shareholders who believe the company manipulated share prices by issuing bullish statements that made things appear better than they actually were during the second half of 1997. Things, in fact, were anything but better. Shareholders point to December 10, 1997, as proof that things were actually not going well at all. On that day, the company announced it would miss fourth quarter revenue goals by as much as 25 percent; as a result the company's share price, which stood as high as $21.50 on the day the company issued its revenue warning, fell nearly 30 percent, to $13 and change. Since then, shares have retreated even further, resting at its current price of $10. Once upon a time, shares of Vivus traded as high as $41.88." The sole difference, of course, lying in the phrase, "as a result the company's share price, which stood as high as $21.50 on the day the company issued its revenue warning, fell nearly 30 percent." It should of course be amended to "gapped nearly 30 percent." Hope that helps, Ivan